# Phase 4 thrombosis trials recruiting: 22 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials in phase 4 for thrombosis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 thrombosis trials: 22 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/thrombosis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 22
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 1, 2026 | NCT07852637 | Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism | Samsung Medical Center | Phase 4 | Not yet recruiting | Venous Thromboembolism, Active Cancer | 2,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852637) |
| July 20, 2026 | NCT07713875 | Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Spine Metastasis | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07713875) |
| June 12, 2026 | NCT07644247 | STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump | China National Center for Cardiovascular Diseases | Phase 4 | Not yet recruiting | LVAD (Left Ventricular Assist Device) Thrombosis, LVAD, LVAD (Left Ventricular Assist Device), LVAD-related GI Bleed... | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07644247) |
| May 22, 2026 | NCT07602257 | Investigating a Personalized Approach to Anti-Platelet Therapy | Ottawa Heart Institute Research Corporation | Phase 4 | Not yet recruiting | High Risk Bleeding | 1,760 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07602257) |
| January 20, 2026 | NCT07352358 | Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis | Xuanwu Hospital, Beijing | Phase 4 | Recruiting | Cerebral Venous Thrombosis | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07352358) |
| November 21, 2025 | NCT07243080 | Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention | Mayo Hospital Lahore | Phase 4 | Recruiting | Deep Venous Thromboses, Laparotomy Patients | 212 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07243080) |
| September 24, 2025 | NCT07189897 | Apixaban or Enoxaparin After Head and Neck Cancer Surgery | Sponsor not shown (see the record) | Phase 4 | Recruiting | Venous Thromboembolism, Head and Neck Cancer | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07189897) |
| June 5, 2025 | NCT07007143 | STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant | Chinese Academy of Medical Sciences, Fuwai Hospital | Phase 4 | Recruiting | Mitral Regurgitation | 1,032 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07007143) |
| March 30, 2025 | NCT06901466 | STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant | Chinese Academy of Medical Sciences, Fuwai Hospital | Phase 4 | Recruiting | Mitral Regurgitation | 880 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06901466) |
| March 12, 2025 | NCT06873321 | VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization | Science Valley Research Institute | Phase 4 | Recruiting | Peripheral Arterial Disease, Venous Thormboembolism, Cardiovascular Diseases, Vascular Surgery Patient with PAD /... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06873321) |
| October 23, 2024 | NCT06655376 | Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device | Columbia University | Phase 4 | Recruiting | Bleeding, Clot Blood | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06655376) |
| September 19, 2024 | NCT06603870 | Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis | Ottawa Hospital Research Institute | Phase 4 | Recruiting | Venous Thromboembolism, Cancer, Upper Extremity Deep Vein Thrombosis, Catheter-Related Infections | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06603870) |
| September 3, 2024 | NCT06581965 | inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee... | Leiden University Medical Center | Phase 4 | Recruiting | Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism, Deep Vein Thrombosis | 10,078 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06581965) |
| July 29, 2024 | NCT06523959 | Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial | Clinical Urology and Epidemiology Working Group | Phase 4 | Recruiting | Venous Thromboembolism, Bleeding | 5,436 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06523959) |
| July 3, 2024 | NCT06486181 | Second Line Endovascular Treatment in Acute DVT | Rush University Medical Center | Phase 4 | Not yet recruiting | Deep Venous Thrombosis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06486181) |
| November 22, 2023 | NCT06144125 | Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery | Konkuk University Medical Center | Phase 4 | Recruiting | Cardiac Valve Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06144125) |
| November 2, 2023 | NCT06115070 | Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 4 | Not yet recruiting | Thrombosis, Acute Ischemic Stroke (AIS) | 390 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06115070) |
| December 29, 2022 | NCT05667805 | Coagulation in Cirrhosis | Medical University of Vienna | Phase 4 | Recruiting | Liver Cirrhosis | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05667805) |
| February 18, 2022 | NCT05245877 | Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery | Helsinki University Central Hospital | Phase 4 | Recruiting | Pancreas Cancer, Pancreas Neoplasm, Surgery, Thrombosis, Bleeding | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05245877) |
| February 1, 2021 | NCT04731558 | Pre- Vs Postoperative Thromboprophylaxis for Liver Resection | Helsinki University Central Hospital | Phase 4 | Recruiting | Liver Cancer, Surgery, Thrombosis, Deep Vein, Embolism, Pulmonary, Bleeding | 1,012 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04731558) |
| June 18, 2020 | NCT04436978 | What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? | St. Antonius Hospital | Phase 4 | Recruiting | Acute Coronary Syndrome, Myocardial Infarction, Atrial Fibrillation, Atrial Flutter, STEMI - ST Elevation Myocardial... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04436978) |
| February 10, 2020 | NCT04263038 | Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism | Sponsor not shown (see the record) | Phase 4 | Recruiting | Pulmonary Embolism, Embolism, Embolism and Thrombosis, Lung Diseases, Cardiovascular Diseases, Respiratory Tract... | 276 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04263038) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 2 |
| Helsinki University Central Hospital | 2 |
| Ottawa Hospital Research Institute | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Clinical Urology and Epidemiology Working Group | 1 |
| Ottawa Heart Institute Research Corporation | 1 |
| Samsung Medical Center | 1 |
| Leiden University Medical Center | 1 |
| Konkuk University Medical Center | 1 |
| Columbia University | 1 |
| Medical University of Vienna | 1 |
| St. Antonius Hospital | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Mayo Hospital Lahore | 1 |
| Science Valley Research Institute | 1 |
| Rush University Medical Center | 1 |
| Xuanwu Hospital, Beijing | 1 |

## By country

| Country | Trials |
| --- | --- |
| Canada | 4 |
| China | 4 |
| United States | 4 |
| Netherlands | 3 |
| Finland | 3 |
| Belgium | 2 |
| Norway | 2 |
| South Korea | 2 |
| France | 1 |
| Switzerland | 1 |
| Austria | 1 |
| Pakistan | 1 |
| Brazil | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Engineering schools in the United States](https://specstream.ai/data/businesses/engineering-schools/united-states)
- [Mortgage lenders in the United States](https://specstream.ai/data/businesses/mortgage-lenders/united-states)
- [Tower communication companies in the United States](https://specstream.ai/data/businesses/tower-communication-companies/united-states)
- [Chicken restaurants in the United States](https://specstream.ai/data/businesses/chicken-restaurants/united-states)
- [Hydraulic repair companies in the United States](https://specstream.ai/data/businesses/hydraulic-repair-companies/united-states)
- [Pulmonology practices in the United States](https://specstream.ai/data/businesses/pulmonology-practices/united-states)
